Refining clinical judgment of treatment outcome in obsessive-compulsive disorder

被引:64
作者
Lewin, Adam B. [1 ]
De Nadai, Alessandro S. [2 ]
Park, Jennifer [2 ]
Goodman, Wayne K. [3 ]
Murphy, Tanya K. [1 ]
Storch, Eric A. [1 ]
机构
[1] Univ S Florida, Dept Pediat, Rothman Ctr Neuropsychiat, Coll Med, St Petersburg, FL 33701 USA
[2] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA
[3] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA
关键词
Obsessive-compulsive disorder; Treatment response; Cognitive-behavioral therapy; Drug therapy; Yale-Brown Obsessive Compulsive Scale; COGNITIVE-BEHAVIORAL THERAPY; PLACEBO-CONTROLLED TRIAL; DEFINING RESPONSE; SCALE; EXPOSURE; PSYCHOTHERAPY; CLOMIPRAMINE; FLUOXETINE; MEANINGFUL; PREVENTION;
D O I
10.1016/j.psychres.2010.08.021
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
This research aimed to provide clinicians and investigators with optimal treatment outcome criteria for accurately predicting response and remission in both research studies and clinical practice. Data from 153 adult OCD outpatients (ages 18-79) who had participated in a treatment outcome study were examined. Signal detection analysis was conducted to compare levels of Yale-Brown Obsessive Compulsive Scale (Y-BOCS) symptom percent reductions and post treatment absolute scores with Clinical Global Impression (CGI) ratings of symptom improvement and severity. Optimal cutoff criteria were based on sensitivity, specificity and efficiency and were assessed via the Quality Receiver Operating Characteristic curve. A Y-BOCS reduction of 45% was observed to be the most efficient for predicting response in research trials, whereas a reduction of 35% may be optimal for clinical use. A 55% Y-BOCS reduction was determined to be the optimal cutoff for predicting remission in both clinical and research settings. A Y-BOCS absolute raw score of 12 or less was optimal for predicting remission in a clinical setting and a raw score of 14 or below was most favorable in research trials. This research provides the first empirical contrast of optimal outcome criteria in OCD based on differing ideals of both research and practice. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:394 / 401
页数:8
相关论文
共 51 条
  • [1] Obsessive-compulsive disorder
    Abramowitz, Jonathan S.
    Taylor, Steven
    McKay, Dean
    [J]. LANCET, 2009, 374 (9688) : 491 - 499
  • [2] [Anonymous], 1995, CLIN PSYCHOL-UK, V28, P3, DOI DOI 10.1037/E554972011-003
  • [3] [Anonymous], 1996, SCI PSYCH S
  • [4] [Anonymous], 2000, FORCE DSM 4 DSM 4 T, DOI 10.1176/dsm10.1176/appi.books.9780890420249.dsm-iv-tr
  • [5] A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder
    Arnold, LM
    Rosen, A
    Pritchett, YL
    D'Souza, DN
    Goldstein, DJ
    Iyengar, S
    Wernicke, JF
    [J]. PAIN, 2005, 119 (1-3) : 5 - 15
  • [6] Brown T.A., 2004, ANXIETY DISORDERS IN
  • [7] DIAGNOSTIC-ACCURACY OF THE CHILD-BEHAVIOR CHECKLIST SCALES FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER - A RECEIVER-OPERATING CHARACTERISTIC ANALYSIS
    CHEN, WJ
    FARAONE, SV
    BIEDERMAN, J
    TSUANG, MT
    [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1994, 62 (05) : 1017 - 1025
  • [9] A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder
    Cottraux, J
    Note, I
    Yao, SN
    Lafont, S
    Note, B
    Mollard, E
    Bouvard, M
    Sauteraud, A
    Bourgeois, M
    Dartigues, JF
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2001, 70 (06) : 288 - 297
  • [10] The Yale-Brown Obsessive Compulsive Scale: factor analysis, construct validity, and suggestions for refinement
    Deacon, BJ
    Abramowitz, JS
    [J]. JOURNAL OF ANXIETY DISORDERS, 2005, 19 (05) : 573 - 585